Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$617,706
+$144,025 QoQ
Shares Held
515
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#3,570
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CoreFirst Bank & Trust holds $7,786,859 across 11 Drug Manufacturers - General names. LLY ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,471 | $2,913,289 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,877 | $1,140,694 | |
| 3 | AMGN |
Amgen Inc
|
2,643 | $957,082 | |
| 4 | ABBV |
AbbVie Inc.
|
3,751 | $943,900 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
515 | $617,706 | |
| 6 | NVS |
Novartis AG
|
3,525 | $552,438 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,427 | $255,083 | |
| 8 | NVO |
Novo Nordisk A S
|
4,723 | $226,420 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $617,706 | 515 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $473,681 | 515 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $644,808 | 600 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $724,850 | 950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $740,553 | 950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $784,614 | 950 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $733,400 | 950 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $885,940 | 1,000 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $905,380 | 1,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $777,960 | 1,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $582,920 | 1,000 | Shares | Sole | 2024-03-18 | |
| 2023-09-30 | $644,556 | 1,200 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $562,776 | 1,200 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $412,104 | 1,200 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $439,008 | 1,200 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $388,020 | 1,200 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $389,076 | 1,200 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $286,370 | 1,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $276,220 | 1,000 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $231,050 | 1,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $229,520 | 1,000 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $203,633 | 1,090 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $168,840 | 1,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||